Furthermore, the inhibition of NF-κB signaling reversed the chemoprotective effect of BM niche cells exposed to tumor-targeting agents in a biomimetic model of B-ALL [37]. Here, NFKB1 is linked to precursor B-cell acute lymphoblastic leukemia.